Overview
The study is based on the constitution of a collection of tumor and blood samples for the development of tumoroid for functional tests to predict clinical response to treatment.
Eligibility
Inclusion Criteria:
- Patient with undifferentiated primary carcinoma (UPC) with histological and immunohistochemical evidence, validated in a local and/or national UPC multidisciplinary consultation
- Patient with indication for 1st-line treatment at the time of inclusion.
- Patient with life expectancy greater than 3 months
- Patient of legal age
- Patient affiliated to a social security scheme
- Signature of informed consent prior to any specific study procedure
Exclusion Criteria:
- Persons deprived of their liberty or under guardianship (including curatorship)
- Pregnant or breast-feeding patient